A significant advance in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This crucial malignant protector protein is frequently disabled in various forms of malignancies, leading https://bookmarkextent.com/story24146070/nanobodies-revive-the-p53-protein-the-new-pathway-for-cancer-management